Treatment of Herpes Simplex Virus Types 1 and 2 Encephalitis in Mice with 9-β- d -Arabinofuranosyladenine
Authors:
Open Access
- 1 January 1973
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 3 (1) , 74-80
Abstract
The susceptibility of herpes simplex type 1 and type 2 viruses to 9-β- d -arabinofuranosyladenine (ara-A) was tested in intracerebrally infected mice. Subcutaneously administered ara-A resulted in markedly equivalent and reproducible chemotherapeutic activity against both serotypes of herpes simplex viruses. Administration of ara-A by several different intermittent dosage regimens showed that change in pattern of response in terms of survivors appears to be influenced more by total amount of drug administered than by schedule or duration of drug treatment. In general, surviving drug-treated, virus-infected animals survived rechallenge with 1,000 LD 50 of the respective homologous virus inoculated intracerebrally on the 21st day after the initial virus inoculation. A neutralization test performed in vitro-in vivo confirmed the identity of the two distinct serotypes of herpes simplex virus employed. The data indicate that the genital form of herpes simplex virus (type 2) is as sensitive as the oral-mouth form (type 1) to the significant therapeutic activity of ara-A.Keywords
This publication has 16 references indexed in Scilit:
- Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2′-Deoxyuridine and 9-β- d -ArabinofuranosyladenineInfection and Immunity, 1970
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.1969
- Herpesvirus Type 2: Association with Carcinoma of the CervixScience, 1968
- Relation of Pock Size on Chorioallantoic Membrane to Antigenic Type of Herpesvirus HominisExperimental Biology and Medicine, 1968
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. 3. Reduction in evidence of encephalitis in treated herpes Simplex-infected hamsters.1968
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.1968
- Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice.1968
- Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.1968
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)Chemotherapy, 1968
- HERPES SIMPLEX VIRUS AND PARALYSIS OF ANIMALS1966